Evidence map›Paper›PMID 36345367›Full record

ArticleIJID regions2022

Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study.

Bulemba Katende, Lucia González Fernández, Josephine Muhairwe, Tracy R Glass, Irene Ayakaka, Niklaus D Labhardt, Morten Ruhwald, Margaretha de Vos, Moniek Bresser, Klaus Reither

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Bulemba KatendeSolidarMed, Partnerships for Health, Maseru, Lesotho.
Lucia González FernándezSolidarMed, Partnerships for Health, Lucerne, Switzerland.
Josephine MuhairweSolidarMed, Partnerships for Health, Maseru, Lesotho.
Tracy R GlassSwiss Tropical and Public Health Institute, Basel, Switzerland.
Irene AyakakaSolidarMed, Partnerships for Health, Maseru, Lesotho.
Niklaus D LabhardtSwiss Tropical and Public Health Institute, Basel, Switzerland.
Morten RuhwaldFIND, the global alliance for diagnostics, Geneva, Switzerland.
Margaretha de VosFIND, the global alliance for diagnostics, Geneva, Switzerland.
Moniek BresserSwiss Tropical and Public Health Institute, Basel, Switzerland.
Klaus ReitherSwiss Tropical and Public Health Institute, Basel, Switzerland.
Swiss Tropical and Public Health Institute · CHFIND · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.

Indexed as

bioaerosol capture deviceCOVID-19LesothoSARS-CoV-2

Identifiers

PMID36345367
PMCPMC9630292
OpenAlexW4308489131

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.